Improved adherence to practice guidelines yields better outcome in high-risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies

Journal of Internal Medicine
S VikmanK Niemelä

Abstract

Treatment options for acute coronary syndrome (ACS) without ST elevation have evolved rapidly during the recent years, but the successful implementation of practice guidelines incorporating new treatments into practice has been challenging. In this study, we evaluate whether targeted educational intervention could improve adherence to treatment guidelines of ACS without ST elevation. A previous study, FINACS I, evaluated the treatment and outcome of 501 consecutive non-ST elevation ACS patients that were referred in early 2001 to nine hospitals, covering nearly half of the Finnish population. That study revealed poor adherence to ESC guidelines, so targeted educational intervention on optimal practice was arranged before the second study (FINACS II), which was performed in the same hospitals using the same protocol as FINACS I. FINACS II, undertaken in early 2003, evaluated 540 consecutive patients. Interventions. Targeted educational programmes on optimal practice. The use of evidence-based therapies in non-ST elevation ACS patients. In-hospital event-free (death, new myocardial infarction, refractory angina, readmission with unstable angina and transient cerebral ischaemia/stroke) survival, and event-free survival at 6 months...Continue Reading

References

Sep 6, 1995·JAMA : the Journal of the American Medical Association·D A DavisR B Haynes
May 15, 1998·JAMA : the Journal of the American Medical Association·T A MarciniakS F Jencks
May 15, 1998·JAMA : the Journal of the American Medical Association·S B SoumeraiF Gobel
Jan 28, 1999·The New England Journal of Medicine·J ChenH M Krumholz
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Jun 29, 2000·Archives of Internal Medicine·R P GiuglianoC J O'Donnell
Dec 8, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·G Bernardi
Dec 8, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·M Galli
Jun 23, 2001·The New England Journal of Medicine·C P CannonUNKNOWN TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis
May 30, 2003·The New England Journal of Medicine·Ashish K JhaR Adams Dudley

❮ Previous
Next ❯

Citations

Apr 7, 2009·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Jack D McCueKevin Smothers
May 13, 2010·Critical Care : the Official Journal of the Critical Care Forum·Teresa CardosoAltamiro Costa-Pereira
Mar 15, 2006·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Phillip V AsaroDouglas M Char
Aug 1, 2014·Journal of Cardiac Failure·Tuukka TarvasmäkiUNKNOWN FINN-AKVA Study Group
Sep 14, 2007·Scandinavian Cardiovascular Journal : SCJ·Saila VikmanKari Niemelä
Jun 28, 2006·The Canadian Journal of Cardiology·David H FitchettUNKNOWN Renewal of Non STE ACS Algorism Group
Mar 11, 2016·Current Cardiology Reports·Apurva O BadhekaMauricio G Cohen
Oct 1, 2008·British Journal of Clinical Pharmacology·Rikke SørensenS Z Abildstrom
Jun 5, 2007·Internal Medicine Journal·D Y LeungC P Juergens
Mar 25, 2014·Acute Cardiac Care·Peter W RadkeJulian Halcox
Jun 15, 2011·Journal of Intensive Care Medicine·Lisa StonekingBenson Munger
Feb 19, 2008·The Medical Journal of Australia·Darren L WaltersDavid Brieger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.